Ironwood did not specify in yesterday’s filing how much it plans to raise by selling stock.
(John Tlumacki/Globe Staff/File)
Ironwood Pharmaceuticals plans IPO
Cambridge firm developing drug for bowel ailment
Ironwood did not specify in yesterday’s filing how much it plans to raise by selling stock.
(John Tlumacki/Globe Staff/File)
Ironwood Pharmaceuticals, a Cambridge biotechnology company developing a treatment for irritable bowel syndrome, yesterday filed plans to go public. (Full article: 355 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
